Hemostatic Composition Using Hydrophobic Solvent for Stability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing hemostatic materials, such as thrombin-containing gelatin pastes, face challenges in storage stability due to the decomposition of N-hydroxysuccinimide ester groups when exposed to water, which can compromise their effectiveness in controlling bleeding.

Innovation Solution

A hemostatic material composition incorporating a polysaccharide with reactive groups, crosslinked particles, and a hydrophobic solvent, where the polysaccharide reacts with proteins to form crosslinking structures, and the crosslinked particles absorb water, enhancing storage stability and hemostatic properties.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If a hydrophilic solvent is used in the hemostatic material composition, then the hemostatic material can be properly formulated and applied, but the N-hydroxysuccinimide ester group reacts with water and decomposes, resulting in temporal deterioration of hemostatic properties

Engineering Contradiction:
Improveformulability of hemostatic materialVSAvoidstorage stability of reactive group
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent removes water from the solvent system entirely, extracting the harmful element (water) that causes decomposition of the N-hydroxysuccinimide ester group. The composition uses an anhydrous organic solvent instead of a hydrophilic solvent, eliminating the water-reactive pathway while maintaining formulability through alternative solvent selection.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent changes the fundamental parameter of solvent water content from containing water (hydrophilic) to being completely anhydrous. This parameter change transforms the chemical environment from one where hydrolysis occurs to one where the N-hydroxysuccinimide ester group remains stable, thereby resolving the contradiction between formulability and storage stability.

Inventive Principle:
Principle #35Parameter changes

2Ease of operation

If water is present in the hemostatic material composition, then the material can maintain flexibility and workability, but the reactive group decomposes due to reaction with water, compromising long-term stability

Engineering Contradiction:
Improveworkability of hemostatic materialVSAvoidchemical stability of reactive group
Core Design Contradiction:
Ease of operationVSStability of the object's composition

Solution Approach 1:

The patent introduces an anhydrous organic solvent as an intermediary substance that mediates between the need for material workability and the requirement for chemical stability. This intermediary solvent provides the necessary fluidity and workability without containing water, thus preventing decomposition of the N-hydroxysuccinimide ester group while maintaining operational ease.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Reliability

If the N-hydroxysuccinimide ester group is used for crosslinking, then excellent hemostatic properties are achieved, but the group reacts with trace water and decomposes over time, reducing effectiveness

Engineering Contradiction:
Improvehemostatic effectivenessVSAvoidshelf life of hemostatic material
Core Design Contradiction:
ReliabilityVSDuration of action of stationary object

Solution Approach 1:

The patent applies preliminary anti-action by preventing water from being present in the composition before the N-hydroxysuccinimide ester group can decompose. By formulating the product in an anhydrous environment from the outset, the patent preemptively blocks the hydrolysis reaction pathway, thereby preserving both the hemostatic effectiveness and extending the shelf life of the material.

Inventive Principle:
Principle #9Preliminary anti-action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The composition exhibits improved storage stability and hemostatic performance by preventing decomposition of reactive groups and maintaining effectiveness over time, even when exposed to trace amounts of water.

Implementation Method 1

a polysaccharide having a reactive group that reacts with a protein to form a crosslinking structure

Methodology Applied
Scientific EffectCrosslinking reaction: Chemical Bonding

Implementation Method 2

a hemostatic material composition incorporating a polysaccharide with reactive groups, crosslinked particles, and a hydrophobic solvent

Methodology Applied
Scientific EffectHydrophobic effect: Hydrophobe

Implementation Method 3

the crosslinked particles absorb water, enhancing storage stability and hemostatic properties

Methodology Applied
Scientific EffectAbsorption: Absorption (physical)

Data Source

PatentEP4201438B1Hemostatic material composition
Publication Date: 2024.06.19 FUJIFILM CORP
  • EP4201438B1 patent drawing
  • EP4201438B1 patent drawing
  • EP4201438B1 patent drawing

AI summary

The hemostatic material composition contains a polysaccharide having a reactive group that reacts with a protein to form a crosslinking structure, a hydrophobic solvent, and a crosslinked particle containing one or more compounds selected from the group consisting of a crosslinked protein and a crosslinked polysaccharide.